Hormone & Urinary Metabolites Assessment Profile

202 biomarkers Sample: Urine Peer-reviewed

Biomarkers in this category

202 biomarkers · optimal ranges shown

Percentages of 2-OH-E1, 4-OH-E1, and 16-OH-E1 When evaluating phase I metabolism, it can be helpful to compare the percentages of 2, 4, and 16 OH-E1 metabolites. Most individuals metabolize the majority of their estrogens down the 2-OH-E1 pathway which is generally considered the “safer pathway”. This is followed by 16-OH-E1 and 4-OH-E1 respectively, both of which are deemed more reactive and potentially genotoxic.

17-Hydroxyprogesterone (17-OHP) is a steroid hormone produced by the adrenal glands and ovaries. On a Sex Hormones Profile; Urine (female) panel by Doctor's Data, the 17-Hydroxyprogesterone (Pre-menopausal) marker measures the levels of this hormone in urine. In pre-menopausal women, 17-OHP plays a crucial role in the production of other hormones, including cortisol and estrogen. It is involved in the progesterone synthesis pathway and can help in assessing adrenal and ovarian function. Elevated or abnormal levels of 17-OHP may indicate a variety of conditions, including polycystic ovary syndrome (PCOS), congenital adrenal hyperplasia (CAH), or adrenal gland disorders. Understanding the levels of 17-Hydroxyprogesterone can provide valuable insights into hormonal imbalances and help guide treatment plans. It is typically measured alongside other sex hormones to evaluate the overall hormonal environment in the body and identify any underlying issues that may impact reproductive health, fertility, and general well-being. If you see elevated or abnormal results, it’s important to discuss them with your healthcare provider to determine the next steps and explore potential treatment options.

What is 2-Hydroxyestrone? 2-Hydroxyestrone (2-OHE1) is a metabolite of estrone, one of the primary estrogens in the body. It belongs to the category of hydroxylated estrogen metabolites, specifically produced through phase I detoxification in the liver. This biomarker is considered part of the estrogen metabolism pathway, reflecting how the body processes and eliminates estrogen. Why is it important? 2-Hydroxyestrone is often referred to as the “protective” estrogen metabolite. It plays a crucial role in determining the balance between estrogen metabolites that can either promote or reduce estrogen-related risks. Higher levels of 2-OHE1 are typically associated with a favorable estrogen metabolism profile, while lower levels may suggest a shift toward other estrogen metabolites that could potentially increase the risk of conditions related to estrogen dominance. Clinical Significance Protective Role: 2-Hydroxyestrone is linked to reduced estrogenic stimulation of tissues, which may lower the risk of hormone-sensitive conditions such as breast and endometrial cancer. Estrogen Balance: Measuring 2-OHE1 helps assess overall estrogen metabolism and its balance with other estrogen metabolites, such as 16α-hydroxyestrone (16α-OHE1), which is considered a more proliferative form. The 2-OHE1 to 16α-OHE1 ratio is a key indicator of healthy estrogen metabolism. Liver Detoxification Status: Since this metabolite is produced in the liver during phase I detoxification, it can also provide insights into liver function and detoxification capacity. How to Support Healthy 2-Hydroxyestrone Levels Diet: Consume cruciferous vegetables (e.g., broccoli, kale, cauliflower) rich in indole-3-carbinol (I3C), which promotes healthy estrogen metabolism. Liver Support: Nutrients like B vitamins, magnesium, and antioxidants can aid liver detoxification pathways. Lifestyle Factors: Regular exercise, stress management, and maintaining a healthy weight may improve estrogen metabolism and balance.

2-Methoxyestrone (Pre-menopausal) is a biomarker measured in hormone testing that provides valuable insights into estrogen metabolism, particularly in premenopausal women. This metabolite of estrone, one of the primary forms of estrogen, is produced through the methylation of estrone, a process facilitated by enzymes in the liver. The level of 2-methoxyestrone in the body reflects how estrogen is processed and can be an important marker for evaluating overall hormonal health and balance. In premenopausal women, 2-methoxyestrone can provide insights into various aspects of hormonal regulation, including: Estrogen metabolism: Elevated or imbalanced levels of 2-methoxyestrone may indicate altered estrogen metabolism, which could contribute to hormone-related conditions. Estrogen-related cancer risk: Research has suggested that the ratio of different estrogen metabolites, including 2-methoxyestrone, can influence the risk of hormone-related cancers, such as breast cancer. Imbalances in estrogen metabolism may increase the formation of more harmful estrogen metabolites, raising the risk of such conditions. Endocrine function: Abnormal levels of 2-methoxyestrone can also signal potential issues with the endocrine system, particularly with the liver’s ability to process estrogen efficiently. Role in Hormonal Balance 2-Methoxyestrone is part of a broader group of estrogen metabolites that include other important compounds such as 2-hydroxyestrone and 16α-hydroxyestrone. The balance between these metabolites is significant for maintaining hormonal harmony. A higher ratio of 2-hydroxyestrone to 16α-hydroxyestrone, for example, is generally considered protective against estrogen-driven cancers, while lower levels of 2-methoxyestrone can indicate a shift toward potentially harmful estrogenic pathways. Testing and Clinical Relevance Measuring 2-methoxyestrone in urine or serum as part of a comprehensive hormone panel offers an in-depth look at estrogen metabolism. This non-invasive testing method provides several advantages: It helps assess how the body processes estrogen and whether there are any metabolic imbalances. It can be used to evaluate the risk of developing hormone-dependent cancers. It provides insights into liver function, as the liver plays a key role in estrogen metabolism. Interpretation and Clinical Considerations When interpreting 2-methoxyestrone levels, healthcare practitioners will consider the patient’s menstrual cycle phase, age, and other clinical factors. Hormonal fluctuations throughout the cycle can affect the levels of estrogen metabolites, and therefore, the timing of the test is important. Any variations in the results may help guide treatment options for hormonal imbalances, cancer risk management, or liver health optimization. Understanding the role of 2-methoxyestrone in premenopausal women helps in developing personalized approaches for maintaining optimal hormonal health and reducing the risk of estrogen-related health conditions.

Percentages of 2-OH-E1, 4-OH-E1, and 16-OH-E1 When evaluating phase I metabolism, it can be helpful to compare the percentages of 2, 4, and 16 OH-E1 metabolites. Most individuals metabolize the majority of their estrogens down the 2-OH-E1 pathway which is generally considered the “safer pathway”. This is followed by 16-OH-E1 and 4-OH-E1 respectively, both of which are deemed more reactive and potentially genotoxic.

2-OH-E1 % (Pre-menopausal) shows what share of estrone is routed down the 2-hydroxylation pathway to 2-hydroxyestrone—a distribution metric, not a disease diagnosis. A lower percentage suggests a relative shift toward 4-/16-hydroxylation, while a higher percentage indicates more 2-OH routing, which is generally fine if 2-methoxy metabolites are adequate (reflecting healthy COMT/methylation). Your result can be influenced by diet (crucifers, I3C/DIM), alcohol, medications/smoking, cycle timing, and collection quality. Interpret against your lab’s reference range, aim for balanced pathways (not “max 2-OH”), and consider food-first methylation support, fiber, sleep, stress management, and clinician guidance if patterns are off.

21-Hydroxyprogesterone (21-OHP) is a steroid hormone primarily produced by the adrenal glands. It plays a key role in the synthesis of cortisol, an essential hormone for managing stress and regulating metabolism. On the Sex Hormones Profile; Urine (female) panel by Doctor's Data, the 21-Hydroxyprogesterone (Pre-menopausal) marker measures the amount of this hormone in the urine. In pre-menopausal women, 21-OHP is important for monitoring adrenal function. Abnormal levels, whether elevated or decreased, can provide insights into several health conditions, particularly those related to the adrenal glands. Elevated levels of 21-OHP are often associated with Congenital Adrenal Hyperplasia (CAH), a genetic disorder that results in an enzyme deficiency affecting cortisol production, leading to increased production of androgens and 21-OHP. This condition can lead to symptoms like irregular menstrual cycles, excessive hair growth, or fertility issues. On the other hand, decreased levels of 21-OHP could indicate adrenal insufficiency or hypofunction, where the adrenal glands are not producing enough of the hormone. This may point to conditions like Addison's disease or other disorders affecting adrenal gland function. Measuring 21-Hydroxyprogesterone in urine can help provide a more comprehensive understanding of adrenal health, especially when combined with other sex hormones.

Higher levels indicate slowed COMT activity (methylation) and are associated with a higher risk for breast cancer in females. Due to the lack of research in this area, it may be postulated that men carry a similar risk. Elevation may also be due to an overactive CYP1B1 enzyme or sluggish CYP1A1 or CYP34A. Additional support for the COMT enzyme can help with the conversion toward the inactive metabolite, 4-M-E1.

Methyl metabolites are considered inactive and are correlated with antiproliferative effects. Proper elimination of 4-M-E2 requires optimal excretion via GI tract optimization. To fully understand this value, it may be beneficial to examine the 4-M-E2 / 4-OH-E2 ratio.

Percentages of 2-OH-E1, 4-OH-E1, and 16-OH-E1 When evaluating phase I metabolism, it can be helpful to compare the percentages of 2, 4, and 16 OH-E1 metabolites. Most individuals metabolize the majority of their estrogens down the 2-OH-E1 pathway which is generally considered the “safer pathway”. This is followed by 16-OH-E1 and 4-OH-E1 respectively, both of which are deemed more reactive and potentially genotoxic.

4-OH-E1 : 2-OH-E1 is a urine ratio that shows whether your estrone (E1) is routed more toward the 4-hydroxylation or 2-hydroxylation pathway. It’s a distribution marker, not a raw hormone level, and should be read with methoxy estrogens (COMT function), total estrogen output, and cycle timing. A higher ratio means relatively more 4-OH vs. 2-OH and invites a check of 4-methoxy-E1/2-methoxy-E1, diet (crucifers, fiber, alcohol), sleep/stress, and medications that influence liver enzymes. A lower/balanced ratio is often fine if methoxy metabolites are adequate. This marker doesn’t diagnose disease or predict cancer risk by itself—use it to guide food-first adjustments and, if needed, clinician-guided changes.

5-Pregnenetriol (Pre-menopausal) is a metabolite of pregnenolone, a precursor hormone produced primarily in the adrenal glands, ovaries, and brain. On the Sex Hormones Profile; Urine (female) panel by Doctor's Data, 5-pregnenetriol levels are measured to provide insights into the body’s steroid hormone metabolism, particularly as it relates to adrenal and ovarian function. Pregnenolone serves as the starting point for the production of various other hormones, including progesterone, cortisol, and estrogen. The metabolism of pregnenolone into 5-pregnenetriol is one of the pathways through which the body processes these hormones. Measuring 5-pregnenetriol can offer valuable information about how well the body is processing pregnenolone and can reflect the balance of steroid hormones produced by the adrenal glands and ovaries. In pre-menopausal women, 5-pregnenetriol levels can vary due to factors like stress, hormonal imbalances, or ovarian function. Elevated or decreased levels of 5-pregnenetriol may suggest issues with adrenal hormone production or ovarian function, potentially pointing to conditions like adrenal insufficiency, polycystic ovary syndrome (PCOS), or other hormonal imbalances. Elevated levels of 5-pregnenetriol could indicate increased production of pregnenolone and a shift toward higher steroid hormone output, which may be seen in cases of adrenal hyperactivity or PCOS. Decreased levels may reflect adrenal insufficiency, where the adrenal glands are not producing enough pregnenolone, or other conditions affecting steroidogenesis (the process by which steroids are made in the body). 5-pregnenetriol testing provides a broader understanding of how the body processes and balances various steroid hormones, aiding in the diagnosis of hormonal disorders, adrenal dysfunction, and conditions affecting overall endocrine health. If your results show abnormal levels, further investigation into adrenal and ovarian function may be necessary to determine the underlying cause and guide appropriate treatment.

The metabolic prioritization for alpha or beta reductase activity within the progesterone pathway may be confirmatory of a general preference of metabolism. Comparing these results with the metabolic preference of androgens and corticoids may provide additional insight.

The metabolic prioritization for alpha or beta reductase activity within the progesterone pathway may be confirmatory of a general preference of metabolism. Comparing these results with the metabolic preference of androgens and corticoids may provide additional insight.

Metabolites of progesterone are measured in urine, including 5b-pregnanediol and 5a-pregnanediol. 5b-pregnanediol is inactive in the body but is the major metabolite of progesterone. 5a-pregnanediol is often a metabolite of more interest, as it can cross the blood brain barrier and up-regulate GABA activity and is considered neuroprotective to the brain. Both taken together represent the major metabolic end points for progesterone and can be used to represent total progesterone production. Progesterone is produced by the corpus luteum following ovulation and to a lesser extent by the adrenal glands in both sexes. While found in the urine in small amounts, progesterone can be seen as a clinical marker of luteul activity and theraputic oral progesterone administration. The most important progesterone metabolite, pregnanediol (PDL), can serve as a urinary marker for endogenous progesterone levels and as an indicator of ovulation. PDL exists as two isomers, 5a-pregnanediol and 5b-pregnanediol. 5b-pregnanediol represents the majority end point of endogenous progesterone metabolism and appears to have little activity within the body, while 5α-pregnanediol, the lesser metabolite of PDL, can cross the blood brain barrier and may partially agonize GABA-A receptors. This action is possibly due to its role as an immediate precursor to allopregnanolone. Allopregnanolone is a potent neuroactive steroid capable of binding the GABA-A receptor often leading to sedative and anxiolytic action. The calming action of allopregnanolone is often seen with orally supplemented progesterone, as the liver metabolizes a large portion of oral progesterone to the neuroactive steroid allopregnanolone.

5α-Pregnanediol is a urinary metabolite of progesterone that reflects luteal-phase progesterone output and the body’s 5α-reductase activity; on a HUMAP it’s best interpreted from a mid-luteal sample (~5–7 days after ovulation). Elevated levels may indicate robust luteal production, a 5α-dominant metabolism pattern, pregnancy, or exogenous progesterone use; low levels can suggest low luteal progesterone, non-luteal collection, or lower 5α activity. Always view it alongside 5β-pregnanediol and total progesterone metabolites, consider medications and hydration, and correlate with symptoms like PMS, sleep changes, spotting, or cycle length. Practical next steps include confirming timing and ovulation, considering serum mid-luteal progesterone if needed, and supporting ovulation quality through nutrition, stress and sleep, while checking thyroid, iron, and prolactin when cycles are irregular.

5β-Androstanediol (Pre-menopausal) is a metabolite of the androgenic steroid hormone testosterone, and it plays a role in the metabolism of androgens in the body. On the Sex Hormones Profile; Urine (female) panel by Doctor's Data, the 5β-androstanediol marker measures the levels of this metabolite in urine. It is part of a broader assessment of androgen metabolism and can provide insights into both adrenal and ovarian function. 5β-Androstanediol is produced when testosterone undergoes reduction and conversion by the enzyme 5β-reductase. This process occurs in various tissues, including the adrenal glands, ovaries, and peripheral tissues. This metabolite can be a useful marker for evaluating androgenic activity in the body, which is important for understanding overall hormone balance. In pre-menopausal women, androgens like testosterone are produced in smaller amounts compared to men, but they still play a role in maintaining energy levels, muscle mass, and libido. Elevated or decreased levels of 5β-androstanediol can offer insights into how the body is metabolizing testosterone and may reflect underlying conditions related to hormonal imbalance. Elevated levels of 5β-androstanediol might indicate hyperandrogenism, a condition where there is an overproduction of androgens. This could be seen in disorders such as polycystic ovary syndrome (PCOS) or adrenal hyperplasia, where the adrenal glands produce excessive amounts of androgens. Decreased levels of 5β-androstanediol might suggest reduced androgen production or adrenal insufficiency, where the adrenal glands are not producing enough testosterone or other androgens. This could also reflect hypoandrogenism, which may result in symptoms like fatigue, low libido, or reduced muscle mass. Monitoring 5β-androstanediol levels provides valuable insight into androgen metabolism and adrenal and ovarian function. If abnormal levels are detected, further investigation may be needed to determine the cause, whether it be related to adrenal dysfunction, ovarian health, or other hormonal imbalances. Understanding these results can help guide treatment strategies for maintaining hormonal balance and overall health.

Androstenedione is a key biomarker in the Sex Hormones Profile; urine panel by Doctor's Data. This steroid hormone, produced in the adrenal glands and gonads, serves as a precursor to both testosterone and estrogens (estrone and estradiol). In premenopausal women, androstenedione plays a crucial role in maintaining hormonal balance and can offer valuable insights into various health conditions: Hyperandrogenism: Elevated levels of androstenedione may indicate hyperandrogenism, a condition characterized by excess male hormones in women. Breast cancer risk: Research has shown a correlation between higher premenopausal androstenedione levels and an increased risk of breast cancer. Ovarian function: Androstenedione levels help assess ovarian health and can indicate conditions like polycystic ovary syndrome (PCOS). Adrenal function: As a hormone produced by the adrenal glands, androstenedione levels provide important information about adrenal health. The Sex Hormones Profile by Doctor's Data uses urine samples to measure androstenedione and its metabolites. This non-invasive test offers several advantages: It provides a comprehensive overview of sex steroid hormones and their metabolites. Urine testing offers insight into hormone conjugation and liver function. It helps assess endogenous hormone secretion, enzyme activity, and oxidative stress. When evaluating androstenedione results, healthcare practitioners should take into account factors such as the menstrual cycle phase, age, and other clinical considerations to create tailored treatment plans for hormonal imbalances and associated conditions.

Androsterone is the product of androgens metabolized by 5-alpha reductase. It acts as a neurosteroid and a weak potentiator of GABA-A receptor activity.

Cortisol is the main glucocorticoid released from the adrenal gland in response to stress. High levels of cortisol have been reported in cases of Cushing’s disease, malnutrition, early life stress, hypothyroidism, depression, alcoholism, obesity, and critical illness. Additionally, exogenous exposure to glucocorticoids prior to testing may be a source of cortisol elevations.

main glucocorticoid released from the adrenal gland in response to stress

Cortisol / cortisone ratio indicates activity of HSD11B2 activity and assessment of tissue specific concentrations of cortisol, which normally cannot be measured without a biopsy.

main glucocorticoid released from the adrenal gland in response to stress

DHEA-S is a sulfated form of dehydroepiandrosterone (DHEA), a steroid hormone primarily produced by the adrenal glands. It plays a key role as a precursor to sex hormones such as estrogen and testosterone. What does DHEA-S indicate? DHEA-S levels reflect adrenal function and androgen (male hormone) production. It provides insights into hormonal balance, adrenal health, and overall vitality. Why is DHEA-S important? Hormonal Balance: DHEA-S is a precursor to estrogen and testosterone, influencing reproductive health, libido, and mood. Adrenal Health: Elevated levels may suggest adrenal hyperactivity, while low levels can indicate adrenal insufficiency or chronic stress. Aging Marker: DHEA-S naturally declines with age, so levels may help assess biological aging and overall vitality. Common reasons for abnormal DHEA-S levels High DHEA-S: Polycystic Ovary Syndrome (PCOS) Adrenal hyperplasia or tumors Chronic stress Use of DHEA supplements Low DHEA-S: Adrenal insufficiency or dysfunction (e.g., Addison’s disease) Hypopituitarism Aging or menopause Chronic illness or inflammation

DHEA and DHEAs are produced in the adrenal gland and serve as precursors to androgens and estrogens. Due to the interconversion between DHEA and DHEAS via SULT2A1 and/or STS, the sum of these maybe a better representation of total DHEA synthesis.

What are DHEA and DHEA-S? Dehydroepiandrosterone (DHEA) and its sulfated form, DHEA-S (Dehydroepiandrosterone Sulfate), are hormones produced primarily by the adrenal glands. They serve as precursors to androgens and estrogens, the primary sex hormones in the body. DHEA and DHEA-S levels naturally decline with age and play a crucial role in metabolism, mood regulation, immune function, and reproductive health. Why Are DHEA and DHEA-S Important? These markers help assess adrenal function and the balance of sex hormones in women. Since DHEA-S is the more stable, long-lasting form of DHEA in the body, measuring both together provides a comprehensive picture of androgenic activity. When to Consider Testing? DHEA + DHEA-S testing may be recommended if you experience: Fatigue or chronic stress Hormonal imbalances (irregular periods, infertility) Symptoms of PCOS (polycystic ovary syndrome) Low libido or unexplained weight changes Signs of androgen excess (acne, hair thinning, hirsutism) Adrenal dysfunction (Addison’s or Cushing’s syndrome)

Estradiol level is most consistent with exogenous exposure, supplementation, or aromatization of testosterone to estradiol. CYP19, also known as aromatase, can be upregulated raising intracellular estrogens in men which can contribute to increased adiposity, metabolic syndrome, and prostate pathology. CYP19 enzyme is induced during times of stress, exposure to xeno-estrogens, high glycemic diet, excessive adipose tissue, and alcohol consumption.

Evaluation of the estrogen metabolism pathway relies on understanding several key steps of metabolism: the amount of unconjugated estrogens, hydroxylation of E1 and E2, methylation of hydroxy estrogens, and the function of key enzymes. Evaluation of the estrogen metabolism pathway relies on understanding several key steps of metabolism: the amount of unconjugated estrogens, hydroxylation of E1 and E2, methylation of hydroxy estrogens, and the function of key enzymes.

A component of the estrone level may be due to aromatization of androstenedione and testosterone by CYP19 (aromatase) enzyme in adipose tissue, and/or conversion from estradiol due to HSD17B activity. Aromatase up-regulation and increased intracellular estrogens in men may contribute to increased adiposity, metabolic syndrome, and prostate pathology. CYP19 enzyme is induced during times of stress, exposure to xeno-estrogens, high glycemic diet, excessive adipose tissue, and alcohol consumption.

Etiocholanolone is a 5-beta reduced isomer of androsterone, and a major metabolite of testosterone and androstenedione, however it is not active as an androgen.

Testosterone is the major anabolic androgen found in females. Because urinary testosterone levels are independent of circadian rhythm fluctuation, urine may be a better medium than serum to indicate androgen production.

Testosterone is an androgen hormone primarily associated with male characteristics, but it is also crucial for women's health. It plays a significant role in muscle strength, bone density, mood regulation, libido, and energy levels. The Sex Hormones Profile (urine test) by Doctor's Data measures urinary testosterone to assess hormone balance and metabolism in women. What Does Testosterone Do in Women? Although women produce much lower levels of testosterone compared to men, this hormone is vital for: Sexual health and libido Muscle maintenance and bone strength Mood stability and cognitive function Energy regulation Testosterone is produced in the ovaries, adrenal glands, and peripheral tissues. The body converts testosterone into other hormones like estradiol or dihydrotestosterone (DHT), affecting the overall hormonal balance. Why Is This Test Important? The urinary testosterone test helps detect imbalances that may contribute to various health conditions: Low testosterone levels may indicate adrenal insufficiency, chronic stress, or hypothalamic-pituitary dysfunction. Symptoms can include low libido, fatigue, depression, and muscle weakness. High testosterone levels may be linked to polycystic ovary syndrome (PCOS), adrenal hyperplasia, insulin resistance, or androgen-secreting tumors. Symptoms can include hirsutism (excessive hair growth), acne, hair thinning, and menstrual irregularities. Interpretation of Results Normal Range: Provides a baseline for assessing testosterone balance. Elevated Levels: Consider evaluation for androgen excess, PCOS, or adrenal conditions. Low Levels: May suggest adrenal fatigue, estrogen dominance, or reduced ovarian function. Factors Affecting Testosterone Levels in Urine Several factors can influence urinary testosterone levels: Menstrual cycle phase Age and menopausal status Chronic stress and cortisol levels Medications, including hormonal therapies When Should You Consider Testing? You may consider testing urinary testosterone as part of a Sex Hormones Profile if you experience: Persistent fatigue and low energy Low libido or sexual dysfunction Mood swings, anxiety, or depression Irregular periods or infertility Symptoms of androgen excess, such as acne or excess hair growth

Tetrahydrocortisone is a terminal metabolite of cortisone. This metabolite along with the other terminal metabolites can be used to determine metabolized cortisol. Research in elevations or low levels of single terminal metabolites is limited, assessing metabolized cortisol and daily output may provide more clinically more relevant information.

5B-THA is a terminal metabolite of corticosterone. This metabolite in combination with other terminal metabolites can be used to estimate metabolism of corticosterone. While research in elevations or low levels of single terminal metabolites is limited, assessing metabolism may provide valuable information about enzyme activity.

This calculation includes the daily metabolites of cortisol (5-alpha THF, THF) and cortisone (THE) which maybe a better representation of daily cortisol output than measuring cortisol and cortisone alone due to metabolism differences in the liver (with thyroid hormone) and fatty tissues.